Commemorative Series No. 2 · The Drug Money
OUTSPENTNo. 45/54
Kit
Bond
U.S. Senate · R-MO
Taken from pharma & insurers
$9,350
H.R.1 · Medicare drug-price ban · 2003tap to flip ⤺
WHO THEY WORK FORNo. 45/54
Pharma & Health$9,350
Banned Medicare from negotiating drug prices for 19 years. Once it could (2024), prices fell 38–79%. · 108-1-459OUTSPENT
Card 45 of 54 · tap the card to see who they work for
Beyond the check
The check is only the part you can see.
They took
$9,350
The industry spent on the bill
$116M
on drug-industry lobbying in 2003, about ten lobbyists for every senator
Through the leadership PAC
His leadership PAC took bank and drug money (Freddie Mac, Fannie Mae, Amgen, Express Scripts), though no card issuer.
Source: FEC C00410357
The industry figure is lobbying spent on the bill, not a payment to this senator. Source: Public Citizen (2004); Center for Public Integrity. Everything here is documented public record; nothing alleges an illegal act.
Don't recognize a logo? Here's the key.
Pharma & Health$9,350
Johnson & Johnson$6,850
Merck$1,000
Bristol Myers Squibb$1,000
Amgen$500